Market Research Logo

Global HPV Testing Market 2016-2020

Global HPV Testing Market 2016-2020

About HPV Testing

According to Centers for Disease Control and Prevention (CDC), human papillomavirus (HPV) refers to a group of more than 100 related viruses that commonly cause infections and do not have any symptoms. Among these, more than 40 types of HPVs cause highly contagious diseases that are transmitted through direct sexual contact, infecting both male and female genitals. The other types of HPV cause non-genital warts that are not sexually transmitted. Though most HPV infections are harmless and heal on their own, certain high-risk types of genital HPV can be persistent and cause cervical, penile, anal, vaginal, and oropharyngeal cancers. Many individuals, especially women, undergo regular HPV tests as a preventive measure. HPV tests help to detect the viral genetic material in a cell sample taken from the cervix.

Technavio’s analysts forecast the global HPV testing market to grow at a CAGR of 16.17% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global HPV testing market for 2016-2020. To calculate the market size, the report considers only the HPV test products used for genital cancer screening such as cervical cancer.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global HPV Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott Laboratories
  • BD
  • Roche Diagnostics
  • Qiagen
Other prominent vendors
  • Arbor Vita
  • Breakspear Medical
  • Cepheid
  • DAAN Gene
  • DiaCarta
  • Delphi Bioscience
  • Fujirebio Diagnostics
  • Genera Biosystems
  • IncellDx
  • OralDNA Labs
  • Seegene
  • SoloPap
  • Trovagene
Market driver
  • Early detection of cervical cancer to prevent the growing prevalence
  • For a full, detailed list, view our report
Market challenge
  • Pap test: Alternative diagnostic tests for cervical cancer screening
  • For a full, detailed list, view our report
Market trend
  • Expansion of companies in key markets
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global HPV Testing Market 2016-2020

Technavio recognizes the following companies as the key players in the global HPV testing market: Abbott Laboratories, BD, Roche Diagnostics, and Qiagen

Other Prominent Vendors in the market are: Arbor Vita, Breakspear Medical, Cepheid, DAAN Gene, DiaCarta, Delphi Bioscience, Fujirebio Diagnostics, Genera Biosystems, IncellDx, OralDNA Labs, Seegene, SoloPap, and Trovagene

Commenting on the report, an analyst from Technavio’s team said: “HPV and Pap tests help to detect cervical cancer in women. The Pap test identifies changes in cervical cells caused by HPV infection. The HPV test is used to check for HPV genotypes in sample cells. A physician may advise a patient to undergo both HPV and Pap tests for the screening of cervical cancer. The American Cancer Society, the US Preventive Services Task Force, the American Society for Clinical Pathology, and the American Society for Colposcopy and Cervical Pathology have provided guidelines for the testing of cervical cancer in women in the US. These guidelines state that women aged 30-65 years should undergo Pap and HPV co-testing every five years or undergo Pap test every three years.”

According to the report, vendors in the market have developed innovative home-based products that provide quick and accurate test results. This can help to reduce the cost burden on patients and keep cervical cancer at bay. The adoption of HPV home testing kits is growing developing countries owing to increasing awareness, which is striving the market growth.

Further, the report states that HPV screening test is adopted by many healthcare centers as it can predict the risk of cervical cancer. The result can be positive or negative. If positive, then the individual has to undergo Pap test or colposcopy. Through Pap test, the physician can understand the presence of abnormal or precancerous cells in the cervix. HPV test is a better predictor of low cervical cancer risk; however Pap test can be more efficient in those cases. Based on sensitivity and specificity, Pap test is adopted more than HPV testing.



Companies Mentioned

Abbott Laboratories, BD, Roche Diagnostics, Qiagen, Arbor Vita, Breakspear Medical, Cepheid, DAAN Gene, DiaCarta, Delphi Bioscience, Fujirebio Diagnostics, Genera Biosystems, IncellDx, OralDNA Labs, Seegene, SoloPap, Trovagene.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
    • Cervical cancer diagnosis by HPV testing
  • Market landscape
    • Market overview
      • Table Market dynamics: Global HPV testing market
    • Market size and forecast
      • Table Global HPV testing market 2015-2020 ($ millions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by product
    • Table Global HPV testing market by product 2015 and 2020
    • Global HPV testing market by systems
      • Table Market overview: Global HPV testing market by systems
      • Table Global HPV testing market by systems 2015-2020 ($ millions)
      • Table PEST analysis: Global HPV testing market by systems
    • Global HPV testing market by consumables
      • Table Market overview: Global HPV testing market by consumables
      • Table Global HPV testing market by consumables 2015-2020 ($ millions)
      • Table PEST analysis: Global HPV testing market by consumables
  • Market segmentation by end-user
    • Table Global HPV testing market by end-users 2015
    • Hospitals
    • Clinical diagnostic laboratories
      • Table Revenue generated by diagnostic and medical laboratories in US 2009-2014 ($ millions)
    • Physicians' office laboratories
  • Geographical segmentation
    • Table Global HPV testing market by geography in 2015 and 2020 ($ millions)
    • HPV testing market in Americas
      • Table Americas: Market overview of HPV testing
      • Table Comparative percentage of women aged between 20 and 69 who participated in cervical cancer screening in Americas (2003 and 2013)
      • Table HPV testing market in Americas 2015-2020 ($ millions)
      • Table HPV testing market in Americas: Analysis in various countries
      • Table Key takeaway: HPV testing market in the US
      • Table PEST analysis: HPV testing market in the US
      • Table Differences: HPV testing guidelines for cervical cancer testing
    • HPV testing market in EMEA
      • Table EMEA: market overview of HPV testing
      • Table Percentage of women aged 20-69 participated in cervical cancer screening in EMEA in different countries (2003 and 2013)
      • Table HPV testing market in EMEA 2015-2020 ($ millions)
      • Table HPV testing market in EMEA: Analysis in various countries
      • Table Key takeaway: HPV testing market in the UK
      • Table PEST analysis: HPV testing market in the UK
    • HPV testing market in APAC
      • Table APAC: market overview of HPV testing
      • Table HPV testing market in APAC 2015-2020 ($ millions)
      • Table HPV testing market in EMEA: Analysis in various countries
  • Market drivers
    • Early detection of cervical cancer to prevent the growing prevalence
      • Table Estimated number of cervical cancer in women at different age groups 2014
    • Paradigm shift toward use of HPV home-testing kits
      • Table Market impact analysis: HPV home-testing kits
    • Reimbursements for HPV tests
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Pap test: Alternative diagnostic test for cervical cancer screening
    • Limited number of health clinics and healthcare settings in developing countries
    • Lack of uniformity in screening policies
      • Table Lack of uniformity in cervical cancer screening intervals in EMEA
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Expansion of companies in key markets
      • Table Market impact analysis: companies in key market
    • Co-testing with HPV and Pap tests
    • Development of mRNA HPV test
      • Table Market analysis: Companies focusing on mRNA HPV test
  • Vendor landscape
    • Competitive landscape analysis
      • Table Competitive structure analysis of global HPV testing market 2015
      • Table Competitive landscape analysis of global HPV testing market 2015
      • Table Market penetration of various HPV testing manufacturing companies in global (2015)
      • Table Game changing factors for companies to focus on the market
  • Key vendor analysis
    • Abbott Laboratories
      • Table Abbott Laboratories strength assessment
      • Table Abbott Laboratories strategy assessment
      • Table Abbott Laboratories opportunity assessment
    • BD
      • Table BD strength assessment
      • Table BD strategy assessment
      • Table BD opportunity assessment
    • Roche Diagnostics
      • Table Roche Diagnostics strength assessment
      • Table Roche Diagnostics strategy assessment
      • Table Roche Diagnostics opportunity assessment
    • Qiagen
      • Table Qiagen strength assessment
      • Table Qiagen strategy assessment
      • Table Qiagen opportunity assessment
    • Hologic
      • Table Hologic strength assessment
      • Table Hologic strategy assessment
      • Table Hologic opportunity assessment
    • Other prominent vendors
      • Table Other prominent vendors
      • Table Product matrix: HPV testing market analysis
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report